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Prognostic Value of the SYNTAX Score in Predicting In-Hospital Mortality
in Coronary Artery Bypass Patients - An Indian Perspective
Jimmy George,1 Antony George,1 Prabhavathi Bhatt,1 Seetharam Bhatt,1
Cholenahally Nanjappa Manjunath1
1Sri Jayadeva Institute of Cardiovascular Sciences & Research, India
BACKGROUND SYNTAX score is an objective scoring system to assess
severity and extent coronary artery disease. To evaluate the prog-
nostic value of the SYNTAX score in predicting in-hospital mortality in
coronary artery bypass patients, at a tertiary center in India.
METHODS A cohort of 325 patients who underwent Coronary Artery
Bypass surgery was included in this study from June 2011 to May 2014.
They were divided into tertiles according to the SYNTAX score (0-22,
23-33 and above 33). The endpoint was in-hospital mortality.
RESULTS The mortality in SS tertiles were as follows; 0-22¼6%;
23-33¼4.2% and above 33¼14.3%. There was signiﬁcant increase in
mortality in the third tertile (p¼0.0297). SS above 33 had an Odd’s
ratio of 3.036 (p¼0.018) for mortality.
CONCLUSION Severity of coronary artery disease as measured by
Syntax Score of more than 33 is a signiﬁcant predictor of mortality
after Coronary Artery Bypass surgery.
TCTAP A-166
Effects of Obesity and Metabolic Abnormality on the Risk of Cardiovascular
Disease in the Population of the City of Marrakech
Khramaz Mounia1
1CHU Mohamed VI, UCAM, FMPM, PCIM, Morocco
BACKGROUND We aimed to investigate combined effects of obesity
and metabolic abnormality on the risk of cardiovascular disease and
mortality in adults of the city of Marrakech.
METHODS This is a cross-sectional study conducted in 2013 to 2014
among a representative sample of adults in the city of Marrakech in
Morocco. Anthropometric and blood pressure measurements were
collected, and a blood sample was taken. The prevalence of obesity
(body mass index30 kg/m2) and abdominal obesity (waist circum-
ference>102 cm in males or >88 cm in females) was determined. The
inﬂuence of obesity on estimation of the risk of ischemic heart disease
was studied using the Framingham function. A question about the
social status, dietary habits and physical activity were used.
RESULTS A total of 1198 adults (18-75 years) were included in this study
of which 634 were women (39% with menopause). The prevalence of
obesity was 46% (20% has bodymass index> 40 kg/m2). The prevalence
of obesity was 46% (20% has body mass index >40 kg/m2) and the
prevalence of abdominal obesitywas 37%, that typeof obesitywas higher
in women at 54, 1% than in men. The prevalence of hypertension was
higher in obese (39% of obese against 19, 6% of non-obese). Compared
with healthy normal-weight individuals, metabolically healthy over-
weight and obese individuals showed increased risk for hypertension,
coronary artery disease and diabetes. Metabolically abnormal obese in-
dividuals were at the highest risk for cardiovascular diseases.
CONCLUSION Obesity is a complex multifactorial chronic disease
developing from interactive inﬂuences of numerous factors (social,
behavioral, physiological, metabolic, cellular, and molecular); it’s
common in adults and increases the risk of cardiovascular disease and
premature death. We are in need to expand the detection of obesity
and metabolic abnormality by practitioners and raise awareness about
the importance of good eating habits and sports.
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TCTAP A-167
Adherence to Evidence-Based Secondary Preventive Medications and
Outcomes Assessments in Patients with Percutaneous Coronary
Intervention Who Underwent Bare-Metal Versus Drug-Eluting Stenting
Shaban Mohammed,1 AbdulRahman Arabi,1 Ayman El-Menyar,1
Sabir Abdulkarim,1 Awad Al-Qahtani,1 Salah Salah Arafa,1 Amina Sadiq,1
Khalid Al Siyabi,1 Tarek Aboughazala,1 Jassim Al suwaidi1
1Hamad Medical Corporation, Qatar
BACKGROUND The study primary aims to assess patients’ adherence
to evidence based medications (EBM) in terms of dual antiplatelet,
beta blockers (BB), angiotensin converting enzyme inhibitors (ACEI)the angiotensin receptor blockers (ARB) and statins post drug eluting
(DES) and bare metal (BMS) coronary stenting.
METHODS A retrospective cohort study for patients who underwent
percutaneous coronary intervention (PCI) using DES or BMS was con-
ducted at the Heart Hospital, Hamad Medical Corporation, Qatar. Pa-
tients’ demographics, risk factors, clinical presentation, discharge and
outpatient’s follow-up medications were analyzed and compared. End
points included adherence to EBM, re-admission and mortality rate.
RESULTS A total of 557 consecutive PCI patients were enrolled with a
mean age of 5310, of them 85% were males. DES was deployed in 61%
of cases that were mainly used for NSTE-ACS and elective admission.
Language barrier was signiﬁcantly observed within the BMS group
(p¼0.01). Physician compliance to dual antiplatelet, BB, and Statin
was 100% at discharge for both types of stents. The Patients’ adher-
ence to those medications post-discharge was non-signiﬁcantly higher
in DES group (82% vs. 79%), whereas patients adherence over 1 year
was non-signiﬁcantly higher in BMS group (78% vs. 73%). There
admission rate and mortality within 18 months were comparable be-
tween the 2groups (Table 1).
CONCLUSION Despite high adherence to EBM on discharge, 20% of
post PCI patients failed to ﬁll their ﬁrst prescription, irrespective of
their co-morbidities, social economic class or the type of stent. The
majority of those who adhere to the ﬁrst reﬁll continue to take their
medication sat 1 year; these ﬁndings suggest the importance of early
clinic follow up after PCI. As readmission rate is high, further studies
are needed to address patients’ compliance and education.DES (61%) BMS(39) P valueAge 5310 5311 0.22
Arabs 40% 38% 0.75Sex (females) 12% 19% 0.02Low Socioeconomic
class48% 50% 0.55Language barrier 15% 23% 0.01Ist reﬁll* for dual
antiplatelet, BB,
Statins, and ACEI/
ARB81% 79% 0.43Adherence over one
year73% 78% 0.2PPI on discharge 69% 65% 0.25polypharmacy** 83% 87% 0.28Diabetes mellitus 35% 36% 0.91Hypertension 41% 41% 1No visit in 1st year 16% 35% 0.001 for each3 OPD visits 46% 25%
Reason for PCISTEMI 30% 50% 0.001 for allNSTEMI 31% 29%Unstable angina 30% 18%Elective admission 9% 2%Readmission within 18
months24.70% 29% 0.15Mortality 18 months 2.4 2.6 0.97*¼ within 2-3 months post discharge, **¼>5 medication on discharge.
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Effect of Beta-blocker Therapy on Mortality Rates in Stable Coronary
Artery Disease Patients with Normal Left Ventricular Function After
Percutaneous Coronary Intervention.
Seung-Jung Park,1 Se Hun Kang,1 Min Su Kim,1 Hee-soon Park,1
Byeong Joo Bae,1 Sang Soo Cheon,1 Jae Hyung Roh,1 Pil Hyung Lee,1
Mineok Chang,1 Hyun Woo Park,1 Sung Han Yoon,1 Jung-Min Ahn,1
Duk-Woo Park,1 Soo-Jin Kang,1 Seung-Whan Lee,1 Young-Hak Kim,1
Cheol Whan Lee,1 Seong-Wook Park1
1Asan Medical Center, Korea (Republic of)
BACKGROUND Beta-blocker therapy has been shown to beneﬁt pa-
tients presenting with acute myocardial infarction (AMI) or left ven-
tricular (LV) dysfunction. However, whether Beta-blockers provide a
similar beneﬁt in stable coronary artery disease (SCAD) patients with
normal LV function is unknown.
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function who were treated by percutaneous coronary interven-
tion (PCI) was evaluated. Clinical characteristics and discharge med-
ications were examined. All-cause death and acute myocardial
infarction (AMI) were observed for a median of 34.9 months.
RESULTS Patients’ average age was 64  10.1 years and 2782 (65.2%)
were men. Mortalities among 2794 (65.5%) patients who received Beta-
blockers and 1472 (34.5%) who did not were 75 (2.7%) and 54 (3.7%)
patients, respectively. Beta-blockers did not show a signiﬁcant beneﬁt
in mortality and AMI. Unadjusted hazard ratio (HR) for Beta-blocker
was 0.724 (95% CI 0.510 to 1.028, p¼0.071), adjusted HRwas 0.729 (95%
CI 0.507 to 1.047, p¼0.087). Diabetes mellitus (HR 1.689, 95% CI 1.167 to
2.445, p¼0.005) and renal failure (HR 5.244, 95% CI 3.015 to 9.120,
p<0.001) were an independent predictor ofmortality. Renal failure (HR
7.516, 95% CI 3.130 to 18.049) was an independent predictor of AMI.
CONCLUSION Beta-blockers are clearly indicated in heart failure or
AMI with a protective effect against death. However, in SCAD patients
with normal LV function after PCI, no beneﬁcial effect of Beta-blocker
was observed on mortality rates and AMI.
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TCTAP A-168
Efﬁcacy of Catheter Directed Thrombolysis for Stent Occlusion in
Superﬁcial Femoral Artery in Chronic Period
Hitoshi Anzai1
1Ota Memorial Hospital, Japan
BACKGROUND Efﬁcacy of stent for long chronic total occlusion (CTO) in
the superﬁcial femoral artery (SFA) has been hampered by stent occlu-
sion. Balloon dilatation with or without aspiration was applied in treat-
ment of stent occlusion. However, it frequently offers suboptimal result
and accompanies distal embolization, which complicates situation.
METHODS Since Aug 2014, catheter directed thrombolysis (CDT) ﬁrst
strategy was introduced for patients with stent occlusion after mul-
tiple stent implantations for long SFA CTO. Patients who presented
with acute limb ischemia and underwent stent implantation within
6 months were excluded.
RESULTS CK and D dimer did not elevate before CDT in all patients.
Consecutive 4 patients were treated by catheter directed thrombolysis
(CDT) ﬁrst strategy. CDT was performed without balloon dilatation at
ﬁrst session. Urokinase (720000 IU / day) was continuously adminis-
tered for several days (2 - 5 days). At second session, antegrade blood
ﬂow was restored with residual stenosis in all patients. Subsequent
ballooning provided sufﬁcient dilatation without distal embolization.
CONCLUSION CDT ﬁrst strategy is a safe and effective approach for
stent occlusion after multiple stent implantations in long SFA CTO in
chronic period. Further study is needed before this strategy will be
accepted as standard therapy.TCTAP A-169
Long-Term Outcomes After Percutaneous Transluminal Renal Artery
Stenting for Atherosclerotic Renal Artery Stenosis in the Coronary
Drug-Eluting Stent Era: A Japanese Single-Center Retrospective Study
Tetsuya Ishikawa,1 Makoto Muto1
1Saitama Prefectural Cardiovascular and respiratory Disease Center,
Japan
BACKGROUND We ﬁrstly examined the long-term outcomes after
percutaneous transluminal renal angioplasty with stenting (PTRA) for
atherosclerotic renal artery stenosis (ARAS) in a Japanese daily prac-
tice in the coronary drug-eluting stent (DES) era.
METHODS This retrospective, non-randomized, single-center study
was conducted in October 2014. De novo 125 ARAS in 106 patients
treated between September 2006 and February 2014 were enrolled.
Primary clinical endpoint was the incidences of major cardiovascular
cerebral renovascular events (MACCRE), comprising of cardiac death
including unknown origin, onsets of acute coronary syndrome, stroke,
and congestion, and induction of hemodialysis after PTRA. Predictors
of MACCRE were analyzed using Cox proportional hazard model.
RESULTS As patient-base, a total of 98.1% had hypertension, 47.2%
had diabetic, and 84.9% had coronary artery disease (CAD). Of CAD
patients, 92.2%had treated using DES, 40.0% had previous MI, 25.6%
had LMT disease, 34.4% had CTO lesions, 37.7% had BNP level >¼ 100,
31.1% had estimated glomerular ﬁltration rate (eGFR) < 45, and 22.6%
had multiple PAD. As lesion-base, a total of 64.1% had PSV >¼ 250,
90.2% had RAR >¼ 3.0, and 93.6% was stenting under the guidance of
IVUS. Systolic and diastolic BP (SBP and DBP) before treatment
(167 þ/- 25/80 þ/- 14 mmHg) had decreased at followed-up phase
(127 þ/- 15/69 þ/- 11 mmHg; P < 0.001 for both SBP and DBP). Anti-
hypertensive medication was similar at PTRA and at followed-up
phase (2.2 þ/- 1.3 vs. 2.1 þ/-1.2). A total of 87.7% had continued dual
anti-platelet therapy. Estimated glomerular ﬁltration rate (eGFR)
before treatment (54.9 þ/- 16.6) were well preserved at followed-up
phase (52.6 þ/- 19.7). The incidence of MACCRE was 12.6%with the
mean follow-up period of 1,512  886 days. Cumulative MACCRE-free
ratio at 3 year was higher than 90% and at 5 year than 80%. On Cox
regression analysis, eGFR at PTRA was the only independent predictor
of MACCRE (hazard ratio: 1.01, 95% CI: 0.53-0.97, p ¼ 0.031). In 9 cases
of 80 cases, restenosis deﬁned by stenosis >60% and determined by
renal artery duplex and/or angiography was detected.
CONCLUSION The present study ﬁrstly showed the long-term accept-
able clinical outcomes with the favorable patency after stenting for
ARAS in Japanese daily clinical practice under a high use ratio of IVUS.
TCTAP A-170
Examination of Carbon Dioxide Angiography with Cardiac Angiography
Systems Lacking Digital Subtraction Angiography
Mayumi Watanabe1
1Kawakita General Hospital, Japan
BACKGROUND Several reports suggest that carbon dioxide angiog-
raphy (CDA) supported endovascular therapy (EVT) reduces for use of
contrast media in patients with chronic kidney disease. Although CDA
usually performed under the vascular angiography systems with
digital subtraction angiography (DSA), not all hospitals have vascular
angiography systems. In this study, we thought to evaluate the preset
of CDA performed under the coronary angiography systems.
METHODS Toshiba Inﬁnix Celeve CS was used as coronary angiog-
raphy system, and Subtraction images were produced by manual DSA
application. Constructed images were evaluated by contrast to noise
ratio and visual estimation.
RESULTS After the evaluation of images, the following presets were
recommended;
Frame Rate - 15 frames/sec.
Minimum Pulse Width - 5 msec
Additional Frame Number - 10 images
In this condition, efﬁcient images for EVT were produced.
CONCLUSION This examination proved that coronary angiography
system could adapt CDA by using appropriate presets.
